Please use this identifier to cite or link to this item:
Title: Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool
Author: Argilés Huguet, Josep Ma.
Betancourt Suárez, Angélica Maritza
Guàrdia Olmos, Joan
Peró, Maribel
López-Soriano, Francisco J.
Madeddu, Clelia
Serpe, Roberto
Busquets Rius, Sílvia
Keywords: Caquèxia
Anorèxia nerviosa
Qualitat de vida
Anorexia nervosa
Quality of life
Issue Date: 17-Feb-2017
Publisher: Frontiers Media
Abstract: The CAchexia SCOre (CASCO) was described as a tool for the staging of cachectic cancer patients. The aim of this study is to show the metric properties of CASCO in order to classify cachectic cancer patients into three different groups, which are associated with a numerical scoring. The final aim was to clinically validate CASCO for its use in the classification of cachectic cancer patients in clinical practice. We carried out a case -control study that enrolled prospectively 186 cancer patients and 95 age-matched controls. The score includes five components: (1) body weight loss and composition, (2) inflammation/metabolic disturbances/immunosuppression, (3) physical performance, (4) anorexia, and (5) quality of life. The present study provides clinical validation for the use of the score. In order to show the metric properties of CASCO, three different groups of cachectic cancer patients were established according to the results obtained with the statistical approach used: mild cachexia (15 ≤ × ≤ 28), moderate cachexia (29 ≤ × ≤ 46), and severe cachexia (47 ≤ × ≤ 100). In addition, a simplified version of CASCO, MiniCASCO (MCASCO), was also presented and it contributes as a valid and easy-to-use tool for cachexia staging. Significant statistically correlations were found between CASCO and other validated indexes such as Eastern Cooperative Oncology Group (ECOG) and the subjective diagnosis of cachexia by specialized oncologists. A very significant estimated correlation between CASCO and MCASCO was found that suggests that MCASCO might constitute an easy and valid tool for the staging of the cachectic cancer patients. CASCO and MCASCO provide a new tool for the quantitative staging of cachectic cancer patients with a clear advantage over previous classifications.
Note: Reproducció del document publicat a:
It is part of: Frontiers in Psychology, 2017, vol. 8, num. 92
Related resource:
ISSN: 1664-1078
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)
Articles publicats en revistes (Psicologia Social i Psicologia Quantitativa)
Articles publicats en revistes (Institut de Biomedicina (IBUB))

Files in This Item:
File Description SizeFormat 
667836.pdf899.97 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons